Edition:
United States

Profile: Aralez Pharmaceuticals Inc (ARZ.TO)

ARZ.TO on Toronto Stock Exchange

5.88CAD
17 Feb 2017
Change (% chg)

-- (--)
Prev Close
$5.88
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
13,082
52-wk High
$8.75
52-wk Low
$4.07

Aralez Pharmaceuticals Inc. is a Canada-based specialty pharmaceutical company. The Company focuses on acquiring, developing and commercializing products in cardiovascular, pain and other areas. The Company's products include Fibricor, Cambia, Fiorinal, Fiorinal C, Soriatane, Bezalip SR, NeoVisc, Uracyst, Durela, Proferrin, Resultz and Collatamp G. Its development products include YOSPRALA and Bilastine. Fibricor (fenofibric acid) is indicated as a complementary therapy along with diet for the treatment of hypertriglyceridemia, and as a complementary therapy along with diet to reduce elevated low-density lipoprotein cholesterol (LDL-C), total cholesterol (Total-C), triglycerides (TG) and apolipoprotein B (Apo B). Fibricor is also used to increase high-density lipoprotein (HDL) cholesterol (HDL-C) in patients with hypercholesterolemia or mixed dyslipidemia. Cambia (diclofenac potassium for oral solution) is a non-steroidal anti-inflammatory drug (NSAID).

Company Address

Aralez Pharmaceuticals Inc

7100 West Credit Ave Suite 101
MISSISSAUGA   ON   L5N 0E4
P: +1905.8761118

Company Web Links